Basic Oral Care for Hematology-oncology Patients and Hematopoietic Stem Cell Transplantation Recipients: a Position Paper from the Joint Task Force of the Multinational Association of Supportive Care in Cancer/International Society of Oral Oncology...

Overview

Journal Support Care Cancer

Specialties Critical Care
Oncology

Date 2014 Sep 6

PMID 25189149

Citations 80

Authors

Sharon Elad

Judith E Raber-Durlacher

Michael T Brennan

Deborah P Saunders

Arno P Mank

Yehuda Zadik

Barry Quinn

Joel B Epstein

Nicole M A Blijlevens

Tuomas Waltimo

Jakob R Passweg

M Elvira P Correa

Goran Dahllof

Karin U E Garming-Legert

Richard M Logan

Carin M J Potting

Michael Y Shapira

Yoshihiko Soga

Jacqui Stringer

Monique A Stokman

Samuel Vokurka

Elisabeth Wallhult

Noam Yarom

Siri Beier Jensen

Affiliations

Soon will be listed here.

Abstract

Purpose: Hematology-oncology patients undergoing chemotherapy and hematopoietic stem cell transplantation (HSCT) recipients are at risk for oral complications which may cause significant morbidity and a potential risk of mortality. This emphasizes the importance of basic oral care prior to, during and following chemotherapy/HSCT. While scientific evidence is available to support some of the clinical practices used to manage the oral complications, expert opinion is needed to shape the current optimal protocols.

Methods: This position paper was developed by members of the Oral Care Study Group, Multinational Association of Supportive Care in Cancer/International Society of Oral Oncology (MASCC/ISOO) and the European Society for Blood and Marrow Transplantation (EBMT) in attempt to provide guidance to the health care providers managing these patient populations.

Results: The protocol on basic oral care outlined in this position paper is presented based on the following principles: prevention of infections, pain control, maintaining oral function, the interplay with managing oral complications of cancer treatment and improving quality of life.

Conclusion: Using these fundamental elements, we developed a protocol to assist the health care provider and present a practical approach for basic oral care. Research is warranted to provide robust scientific evidence and to enhance this clinical protocol.

Citing Articles

Oral inflammation and microbiome dysbiosis exacerbate chronic graft-versus-host disease.

Kambara Y, Fujiwara H, Yamamoto A, Gotoh K, Tsuji S, Kunihiro M Blood. 2024; 145(8):881-896.

PMID: 39693612 PMC: 11867138. DOI: 10.1182/blood.2024024540.

Evaluation of the Incidence and Stage of Oral Mucositis in Patients Undergoing Hematopoietic Stem Cell Transplantation: A Retrospective Study.

Kara H, Arikan F, Cil Kazan S, Atay Turan S, Oren R Florence Nightingale J Nurs. 2024; 32(3):261-268.

PMID: 39530640 PMC: 11562492. DOI: 10.5152/FNJN.2024.23049.

Taste alterations after hematopoietic cell transplantation: a scoping review.

Dequae C, Raber-Durlacher J, Epstein J, de Vries R, Laheij A Support Care Cancer. 2024; 32(10):687.

PMID: 39320564 PMC: 11424654. DOI: 10.1007/s00520-024-08900-w.

Self-perceived oral health in hemato-oncological patients and the relation to quality of life.

Laheij A, Dillen L, Nur E, Raber-Durlacher J Support Care Cancer. 2024; 32(10):643.

PMID: 39243322 PMC: 11380634. DOI: 10.1007/s00520-024-08849-w.

Oral health management in children with severe congenital neutropenia with periodontitis: Case report.

Tao S, Yao M, Dong Y, Lin X, Sunchuri D, Guo Z Medicine (Baltimore). 2024; 103(30):e39086.

PMID: 39058847 PMC: 11272339. DOI: 10.1097/MD.0000000000039086.

References

Strietzel F, Lafaurie G, Mendoza G, Alajbeg I, Pejda S, Vuletic L . Efficacy and safety of an intraoral electrostimulation device for xerostomia relief: a multicenter, randomized trial. Arthritis Rheum. 2010; 63(1):180-90. DOI: 10.1002/art.27766. View

Parulekar W, Mackenzie R, Bjarnason G, Jordan R . Scoring oral mucositis. Oral Oncol. 1998; 34(1):63-71. DOI: 10.1016/s1368-8375(97)00065-1. View

. Guideline on dental management of pediatric patients receiving chemotherapy, hematopoietic cell transplantation, and/or radiation. Pediatr Dent. 2006; 27(7 Suppl):170-5. View

Mohty M, Apperley J . Long-term physiological side effects after allogeneic bone marrow transplantation. Hematology Am Soc Hematol Educ Program. 2011; 2010:229-36. DOI: 10.1182/asheducation-2010.1.229. View

Shen P, Manton D, Cochrane N, Walker G, Yuan Y, Reynolds C . Effect of added calcium phosphate on enamel remineralization by fluoride in a randomized controlled in situ trial. J Dent. 2011; 39(7):518-25. DOI: 10.1016/j.jdent.2011.05.002. View

Hoffmann T, Bruhn G, Richter S, Netuschil L, Brecx M . Clinical controlled study on plaque and gingivitis reduction under long-term use of low-dose chlorhexidine solutions in a population exhibiting good oral hygiene. Clin Oral Investig. 2001; 5(2):89-95. DOI: 10.1007/s007840100114. View

Ruggiero S, Dodson T, Fantasia J, Goodday R, Aghaloo T, Mehrotra B . American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw--2014 update. J Oral Maxillofac Surg. 2014; 72(10):1938-56. DOI: 10.1016/j.joms.2014.04.031. View

Epstein J, Raber-Durlacher J, Raber-Drulacher J, Wilkins A, Chavarria M, Myint H . Advances in hematologic stem cell transplant: an update for oral health care providers. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2009; 107(3):301-12. DOI: 10.1016/j.tripleo.2008.12.006. View

Yarom N, Ariyawardana A, Hovan A, Barasch A, Jarvis V, Jensen S . Systematic review of natural agents for the management of oral mucositis in cancer patients. Support Care Cancer. 2013; 21(11):3209-21. DOI: 10.1007/s00520-013-1869-5. View

10.

Sivolella S, Lumachi F, Stellini E, Favero L . Denosumab and anti-angiogenetic drug-related osteonecrosis of the jaw: an uncommon but potentially severe disease. Anticancer Res. 2013; 33(5):1793-7. View

11.

Raber-Durlacher J, Laheij A, Epstein J, Epstein M, Geerligs G, Wolffe G . Periodontal status and bacteremia with oral viridans streptococci and coagulase negative staphylococci in allogeneic hematopoietic stem cell transplantation recipients: a prospective observational study. Support Care Cancer. 2013; 21(6):1621-7. DOI: 10.1007/s00520-012-1706-2. View

12.

Raber-Durlacher J, Elad S, Barasch A . Oral mucositis. Oral Oncol. 2010; 46(6):452-6. DOI: 10.1016/j.oraloncology.2010.03.012. View

13.

Sambunjak D, Nickerson J, Poklepovic T, Johnson T, Imai P, Tugwell P . Flossing for the management of periodontal diseases and dental caries in adults. Cochrane Database Syst Rev. 2011; (12):CD008829. DOI: 10.1002/14651858.CD008829.pub2. View

14.

Sonis S . Pathobiology of oral mucositis: novel insights and opportunities. J Support Oncol. 2007; 5(9 Suppl 4):3-11. View

15.

Rankin K, Epstein J, Huber M, Peterson D, Plemons J, Redding S . Oral health in cancer therapy. Tex Dent J. 2009; 126(5):389-97, 406-19, 422-37. View

16.

Benoliel R, Epstein J, Eliav E, Jurevic R, Elad S . Orofacial pain in cancer: part I--mechanisms. J Dent Res. 2007; 86(6):491-505. DOI: 10.1177/154405910708600604. View

17.

Nicolatou-Galitis O, Sarri T, Bowen J, Palma M, Kouloulias V, Niscola P . Systematic review of amifostine for the management of oral mucositis in cancer patients. Support Care Cancer. 2012; 21(1):357-64. DOI: 10.1007/s00520-012-1613-6. View

18.

Epstein J, Thariat J, Bensadoun R, Barasch A, Murphy B, Kolnick L . Oral complications of cancer and cancer therapy: from cancer treatment to survivorship. CA Cancer J Clin. 2012; 62(6):400-22. DOI: 10.3322/caac.21157. View

19.

Boer C, Correa M, Miranda E, De Souza C . Taste disorders and oral evaluation in patients undergoing allogeneic hematopoietic SCT. Bone Marrow Transplant. 2009; 45(4):705-11. DOI: 10.1038/bmt.2009.237. View

20.

Hovan A, Williams P, Stevenson-Moore P, Wahlin Y, Ohrn K, Elting L . A systematic review of dysgeusia induced by cancer therapies. Support Care Cancer. 2010; 18(8):1081-7. DOI: 10.1007/s00520-010-0902-1. View